59 articles – 21 Notices  [english version]
Fiche concise
Ethical reflections on pharmacogenetics and DNA banking in a cohort of HIV-infected patients.
De Montgolfier S., Moutel G., Duchange N., Hervé C., Theodorou I., Leport C.
Pharmacogenetics 12, 9 (2002) 667-75 - http://www.hal.inserm.fr/inserm-00000002
 (12464796) 
Ethical reflections on pharmacogenetics and DNA banking in a cohort of HIV-infected patients.
Sandrine De Montgolfier1, Grégoire Moutel () 1, Nathalie Duchange1, Christian Hervé1, Ioannis Theodorou2, Catherine Leport3
1 :  LEM - Laboratoire d'éthique médicale et médecine légale
Université Paris V - Paris Descartes
Faculté de médecine, 45 rue des Saints-Pères, Paris 75006
France
2 :  Immunologie cellulaire et tissulaire
http://sirius.cervi.chups.jussieu.fr
INSERM : U543 – IFR113 – Université Pierre et Marie Curie (UPMC) - Paris VI
Gh Pitie-Salpetriere 83, Boulevard de L'Hopital 75013 PARIS
France
3 :  Laboratoire de Recherche en Pathologie Infectieuse
Université Paris VII - Paris Diderot
16, rue Henri Huchard 75870 Paris cedex 18
France
The aim of this study was to analyse ethical issues concerning the storage of human biological samples to be used in genetic analyses and pharmacogenetic research based on a French experience of DNA banking in a cohort of human immunodeficiency virus (HIV)-infected patients started on a protease inhibitor-containing treatment. We describe the ethical issues raised during the establishment of a DNA bank, including questions dealing with autonomy, benefit to the patient, information sharing and confidentiality as well as guarantees concerning the storage and use of DNA. The practical applications of themes illustrated theoretically in the literature are discussed. Most of the points raised are not specific to HIV, but some of them may be more accurate due to the characteristics of the HIV population, which is more involved in the social debate through the community life and the increased risk of stigmatization. Our results are summarized in the memorandum and consent form presented in the Appendices. One issue still open to discussion is the way the results of genetic data will be given to the patients. This work should allow other researchers and members of evaluation committees to enrich their considerations and should stimulate discussion on this topic.
Sciences du Vivant/Ethique
Sciences du Vivant/Médecine humaine et pathologie/Maladies infectieuses
Anglais
0960-314X

Articles dans des revues avec comité de lecture
Pharmacogenetics (Pharmacogenetics)
Publisher Wolters Kluwer - Lippincott Williams & Wilkins
ISSN 0960-314X 
12/2002
12
9
667-75

Biological Specimen Banks – Cohort Studies – Confidentiality – DNA – Databases – Factual – Ethics – Medical – Genetic Privacy – Genetic Research – Genetic Screening – HIV Infections – Humans – Informed Consent – Pharmacogenetics – Research Support – Non-U.S. Gov't – Biolo
APROCO study group : collective author
Agence Nationale de Recherches sur le Sida (ANRS, Action Coordonnée n° 7) Association des Professeurs de Pathologie Infectieuse et Tropicale (APPIT) and associated pharmaceutical companies: Abbott, Boehringer-Ingelheim, Roche, Bristol Myers Squib Pharma,
Liste des fichiers attachés à ce document : 
RTF
de_Montgolfier_et_al.rtf(76.9 KB)
PDF
de_Montgolfier_et_al.pdf(216.1 KB)
XHTML
index.xhtml(56.9 KB)